Edesa Biotech (EDSA) Stock Highlights

1.73 | -1.14%

2024-12-21 07:43:00

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side-effects. The companys product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The companys EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.

Statistics

Range Today

1.55 1.75

Volume Today 23.9K

Range 1 Year

1.69 5.99

Volume 1 Year 3.95M

Range 3 Year

1.69 45.5

Volume 3 Year 19.7M

Range 10 Year

1.69 3792.6

Volume 10 Year 86.8M

Highlights

Market Capitalization 7.86M (micro)

Floating Shares 2.44M

Current Price 1.73

Price To Earnings -0.13

Price To Book 2.74

Earnings Per Share -19.78

Payout Ratio 0%

Performance

Latest -1.14%

1 Month -22.77%

3 Months -60.59%

6 Months -58.91%

1 Year -64.4%

3 Years -95.97%

5 Years -94.12%

10 Years -99.95%

Benchmarks

Market Capitalization

335 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

313 / 368

Free Cashflow

62 / 352

Performance 5 years

300 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.